Bromperidol
From Wikipedia, the free encyclopedia
Bromperidol
|
|
Systematic (IUPAC) name | |
4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one | |
Identifiers | |
CAS number | |
ATC code | N05 |
PubChem | |
Chemical data | |
Formula | C21H23BrFNO2 |
Mol. mass | 420.315 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | Oral |
Bromperidol (Bromidol) is a drug which is a butyrophenone derivative. It is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia.
Bromperidol was discovered at Janssen Pharmaceutica in 1966.
[edit] See also
[edit] References
- Poldinger W, Bures E, Haage H, Clinical study with bromperidol, a new butyrophenone derivative, Int Pharmacopsychiatry. 1977;12(1):20-4.
- Dubinsky B, McGuire JL, Niemegeers CJ, Janssen PA, Weintraub HS, McKenzie BE, Bromperidol, a new butyrophenone neuroleptic: a review, Psychopharmacology (Berl). 1982;78(1):1-7.